Ricovir L 

Brand Name : Ricovir L Tablets
Content : Tenofovir Disoproxil Fumarate 300mg,Lamivudine 300mg
Manufactured by : Mylan Pharmaceuticals Private Limited
Form : Tablets
Packing : Pack of 30 tablets
Share :

Related Products

Ricovir L is a combination medication that includes Lamivudine and Tenofovir Disoproxil Fumarate. This combination is primarily used for the treatment of HIV-1 infection and can also be effective in the management of chronic hepatitis B virus (HBV) infection.

Key Components:

  1. Lamivudine (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Lamivudine inhibits the reverse transcriptase enzyme, a key enzyme that HIV uses to convert its RNA into DNA. By mimicking the building blocks of viral DNA, it gets incorporated into the growing DNA chain, leading to chain termination and halting further replication of the virus.
  2. Tenofovir Disoproxil Fumarate (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Similar to Lamivudine, Tenofovir inhibits the reverse transcriptase enzyme. It also gets incorporated into the viral DNA and causes chain termination, thus preventing further viral replication.

Uses:

  • HIV Treatment: Ricovir L is used as part of a combination antiretroviral therapy (ART) regimen for the treatment of HIV-1 infection in adults and children. It helps to lower the viral load, improve immune function, and reduce the risk of HIV transmission.
  • Hepatitis B Treatment: The combination can also be beneficial in treating chronic HBV infection, as both Lamivudine and Tenofovir are active against this virus.

Dosage and Administration:

  • Dosage: The usual recommended dosage for adults and pediatric patients weighing at least 35 kg is one tablet once daily. The specific dosage may vary based on individual health factors, including renal function.
  • Administration: Ricovir L should be taken orally, with or without food. It is important to take the medication at the same time each day for consistency and to maintain even drug levels in the body.

Side Effects:

Common side effects may include:
  • Gastrointestinal Issues: Nausea, diarrhea, abdominal pain.
  • Fatigue.
  • Headaches.
  • Dizziness.
  • Rash.
Serious side effects may include:
  • Kidney Problems: Tenofovir can lead to renal impairment, so regular monitoring of kidney function is necessary.
  • Liver Issues: Liver enzymes should be monitored, especially in patients with pre-existing liver disease.
  • Bone Density Loss: Long-term use may lead to decreased bone mineral density, which requires monitoring in patients at risk.

Recommendations:

  • Regular Monitoring: Patients on Ricovir L should have regular follow-ups to monitor renal function, liver enzymes, and overall health status.
  • Adherence: It is critical to take Ricovir L exactly as prescribed to maximize its effectiveness and minimize the risk of developing drug resistance.
As always, consult your healthcare provider for detailed and personalized information regarding Ricovir L (Lamivudine and Tenofovir Disoproxil Fumarate), including appropriate dosing, potential drug interactions, and management of any side effects.

Ricovir L is a combination medication that includes Lamivudine and Tenofovir Disoproxil Fumarate. This combination is primarily used for the treatment of HIV-1 infection and can also be effective in the management of chronic hepatitis B virus (HBV) infection.

Key Components:

  1. Lamivudine (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Lamivudine inhibits the reverse transcriptase enzyme, a key enzyme that HIV uses to convert its RNA into DNA. By mimicking the building blocks of viral DNA, it gets incorporated into the growing DNA chain, leading to chain termination and halting further replication of the virus.
  2. Tenofovir Disoproxil Fumarate (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Similar to Lamivudine, Tenofovir inhibits the reverse transcriptase enzyme. It also gets incorporated into the viral DNA and causes chain termination, thus preventing further viral replication.

Uses:

  • HIV Treatment: Ricovir L is used as part of a combination antiretroviral therapy (ART) regimen for the treatment of HIV-1 infection in adults and children. It helps to lower the viral load, improve immune function, and reduce the risk of HIV transmission.
  • Hepatitis B Treatment: The combination can also be beneficial in treating chronic HBV infection, as both Lamivudine and Tenofovir are active against this virus.

Dosage and Administration:

  • Dosage: The usual recommended dosage for adults and pediatric patients weighing at least 35 kg is one tablet once daily. The specific dosage may vary based on individual health factors, including renal function.
  • Administration: Ricovir L should be taken orally, with or without food. It is important to take the medication at the same time each day for consistency and to maintain even drug levels in the body.

Side Effects:

Common side effects may include:

  • Gastrointestinal Issues: Nausea, diarrhea, abdominal pain.
  • Fatigue.
  • Headaches.
  • Dizziness.
  • Rash.

Serious side effects may include:

  • Kidney Problems: Tenofovir can lead to renal impairment, so regular monitoring of kidney function is necessary.
  • Liver Issues: Liver enzymes should be monitored, especially in patients with pre-existing liver disease.
  • Bone Density Loss: Long-term use may lead to decreased bone mineral density, which requires monitoring in patients at risk.

Recommendations:

  • Regular Monitoring: Patients on Ricovir L should have regular follow-ups to monitor renal function, liver enzymes, and overall health status.
  • Adherence: It is critical to take Ricovir L exactly as prescribed to maximize its effectiveness and minimize the risk of developing drug resistance.

As always, consult your healthcare provider for detailed and personalized information regarding Ricovir L (Lamivudine and Tenofovir Disoproxil Fumarate), including appropriate dosing, potential drug interactions, and management of any side effects.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Ricovir L is a combination medication that includes Lamivudine and Tenofovir Disoproxil Fumarate. This combination is primarily used for the treatment of HIV-1 infection and can also be effective in the management of chronic hepatitis B virus (HBV) infection.

Key Components:

  1. Lamivudine (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Lamivudine inhibits the reverse transcriptase enzyme, a key enzyme that HIV uses to convert its RNA into DNA. By mimicking the building blocks of viral DNA, it gets incorporated into the growing DNA chain, leading to chain termination and halting further replication of the virus.
  2. Tenofovir Disoproxil Fumarate (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Similar to Lamivudine, Tenofovir inhibits the reverse transcriptase enzyme. It also gets incorporated into the viral DNA and causes chain termination, thus preventing further viral replication.

Uses:

  • HIV Treatment: Ricovir L is used as part of a combination antiretroviral therapy (ART) regimen for the treatment of HIV-1 infection in adults and children. It helps to lower the viral load, improve immune function, and reduce the risk of HIV transmission.
  • Hepatitis B Treatment: The combination can also be beneficial in treating chronic HBV infection, as both Lamivudine and Tenofovir are active against this virus.

Dosage and Administration:

  • Dosage: The usual recommended dosage for adults and pediatric patients weighing at least 35 kg is one tablet once daily. The specific dosage may vary based on individual health factors, including renal function.
  • Administration: Ricovir L should be taken orally, with or without food. It is important to take the medication at the same time each day for consistency and to maintain even drug levels in the body.

Side Effects:

Common side effects may include:

  • Gastrointestinal Issues: Nausea, diarrhea, abdominal pain.
  • Fatigue.
  • Headaches.
  • Dizziness.
  • Rash.

Serious side effects may include:

  • Kidney Problems: Tenofovir can lead to renal impairment, so regular monitoring of kidney function is necessary.
  • Liver Issues: Liver enzymes should be monitored, especially in patients with pre-existing liver disease.
  • Bone Density Loss: Long-term use may lead to decreased bone mineral density, which requires monitoring in patients at risk.

Recommendations:

  • Regular Monitoring: Patients on Ricovir L should have regular follow-ups to monitor renal function, liver enzymes, and overall health status.
  • Adherence: It is critical to take Ricovir L exactly as prescribed to maximize its effectiveness and minimize the risk of developing drug resistance.

As always, consult your healthcare provider for detailed and personalized information regarding Ricovir L (Lamivudine and Tenofovir Disoproxil Fumarate), including appropriate dosing, potential drug interactions, and management of any side effects.

Reviews

There are no reviews yet.

Be the first to review “Ricovir L ”

Your email address will not be published. Required fields are marked *

Ricovir L is a combination medication that includes Lamivudine and Tenofovir Disoproxil Fumarate. This combination is primarily used for the treatment of HIV-1 infection and can also be effective in the management of chronic hepatitis B virus (HBV) infection.

Key Components:

  1. Lamivudine (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Lamivudine inhibits the reverse transcriptase enzyme, a key enzyme that HIV uses to convert its RNA into DNA. By mimicking the building blocks of viral DNA, it gets incorporated into the growing DNA chain, leading to chain termination and halting further replication of the virus.
  2. Tenofovir Disoproxil Fumarate (300 mg)
    • Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI)
    • Mechanism of Action: Similar to Lamivudine, Tenofovir inhibits the reverse transcriptase enzyme. It also gets incorporated into the viral DNA and causes chain termination, thus preventing further viral replication.

Uses:

  • HIV Treatment: Ricovir L is used as part of a combination antiretroviral therapy (ART) regimen for the treatment of HIV-1 infection in adults and children. It helps to lower the viral load, improve immune function, and reduce the risk of HIV transmission.
  • Hepatitis B Treatment: The combination can also be beneficial in treating chronic HBV infection, as both Lamivudine and Tenofovir are active against this virus.

Dosage and Administration:

  • Dosage: The usual recommended dosage for adults and pediatric patients weighing at least 35 kg is one tablet once daily. The specific dosage may vary based on individual health factors, including renal function.
  • Administration: Ricovir L should be taken orally, with or without food. It is important to take the medication at the same time each day for consistency and to maintain even drug levels in the body.

Side Effects:

Common side effects may include:

  • Gastrointestinal Issues: Nausea, diarrhea, abdominal pain.
  • Fatigue.
  • Headaches.
  • Dizziness.
  • Rash.

Serious side effects may include:

  • Kidney Problems: Tenofovir can lead to renal impairment, so regular monitoring of kidney function is necessary.
  • Liver Issues: Liver enzymes should be monitored, especially in patients with pre-existing liver disease.
  • Bone Density Loss: Long-term use may lead to decreased bone mineral density, which requires monitoring in patients at risk.

Recommendations:

  • Regular Monitoring: Patients on Ricovir L should have regular follow-ups to monitor renal function, liver enzymes, and overall health status.
  • Adherence: It is critical to take Ricovir L exactly as prescribed to maximize its effectiveness and minimize the risk of developing drug resistance.

As always, consult your healthcare provider for detailed and personalized information regarding Ricovir L (Lamivudine and Tenofovir Disoproxil Fumarate), including appropriate dosing, potential drug interactions, and management of any side effects.

Reviews

There are no reviews yet.

Be the first to review “Ricovir L ”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Ricovir L